Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
COVID-19 vaccine: the eight technologies being tested | IVVN
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
Vaccines | Free Full-Text | An Update on Self-Amplifying mRNA Vaccine Development | HTML
Vaccines | Free Full-Text | A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda | HTML
Biomaterials and nanomaterials for sustained release vaccine delivery - Luzuriaga - - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
FDA approves potential COVID-19 vaccine by Moderna for second-stage study - UPI.com
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice. - Abstract - Europe PMC
Frontiers | From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape | Immunology
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
RNA vaccine - Wikipedia
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology
Healthcare Provider Q&A
COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show | FiercePharma
December 17, 2020 coronavirus news | CNN
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
